Pharma Talk Podcast: Optimizing Medicine Development for Real-World Efficacy in Patients: A Biopsychosocial Approach
It's estimated that only 20% of health outcomes are due to clinical care, with the remaining 80% as a result of social determinants of health. Medicine development leaders must understand the broader context of patient lives in order to create therapies with real-world efficacy.
In this podcast, Noël Theodosiou joins The Conference Forum Patients as Partners PharmaTalk podcast to discuss how she's working with life science companies to understand and contextualize the real world that patients live in to create therapeutics that fit in the environment to deliver actual impact.
Noël argues that taking an approach that combines biology, psychology and sociology provides companies with decision-making capabilities that connects good business practices with life science's social contracts with patients.
“We need to move away from ‘validating’ our solutions - which is the mindset of a scientist - to co-creating, discovering and exploring together with patients. The idea of co-creation is something that other industries accept as the norm... This approach would significantly transform every step of drug development.”
